Filing Details
- Accession Number:
- 0000950170-24-028788
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-08 17:28:51
- Reporting Period:
- 2024-03-07
- Accepted Time:
- 2024-03-08 17:28:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1582313 | Xenon Pharmaceuticals Inc. | XENE | Pharmaceutical Preparations (2834) | 980661854 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643085 | Steven Gannon | 200 - 3650 Gilmore Way Burnaby A1 V5G 4W8 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2024-03-07 | 1,000 | $46.45 | 14,000 | No | 4 | S | Direct | |
| Common Shares | Disposition | 2024-03-07 | 5,000 | $46.25 | 9,000 | No | 4 | S | Direct | |
| Common Shares | Disposition | 2024-03-07 | 5,000 | $46.30 | 4,000 | No | 4 | S | Direct | |
| Common Shares | Disposition | 2024-03-07 | 2,000 | $46.20 | 2,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $46.3025 to $46.3675, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $46.20 to $46.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Billionaire Hedge Funds
